It has replaced the once performed axillary lymph node dissection (ALND) for the staging of clinically node negative axilla or with 1 or 2 positive sentinel lymph nodes in invasive breast cancer. It is based on randomized clinical data that have demonstrated equivalent survival between SLNB and ALND with reduced morbidity for SLNB alone
Breast cancer awareness